Several Bcl-2 family proteins are frequently overexpressed in various malignancies including lung cancer (Ikegaki et al, 1994), and tumor cells can be sensitized for anti-neoplastic agents by treatment with inhibitors of Bcl-2 family proteins (Oltersdorf et al, 2005; Cragg et al, 2007). Here, BCL2 is linked to lung carcinoma.